Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Genome Biologics Logo
Genome Biologics Growth Score
37
CB Rank
85990
Heat Score
72
Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease
Founded
obfuscation
PrivateVenture - Series Unknown Hessen, Sachsen-Anhalt, Germany1-10 genomebiologics.com
Biotechnology
Genetics
Pharmaceutical
Therapeutics
Overview

Genome Biologics
Total Funding
obfuscation
Growth Score
37
Heat Score
72

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score37
1 pts
in past quarter
Heat Score 72
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Genome Biologics

CB Rank
85990
Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease
Founded
obfuscation
PrivateVenture - Series Unknown Hessen, Sachsen-Anhalt, Germany1-10 genomebiologics.com
Biotechnology
Genetics
Pharmaceutical
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Genome Biologics UG
Operating Status Active
Company Type For Profit
Founders  Jaya Krishnan, Jonathan Ward
About the Company
Genome Biologics are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses where no other treatments have proven effective or ever existed.
Contact Email info@genomebiologics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Therapeutic Target and Drug Discovery Platform
A platform for identifying and developing therapies targeting cardiovascular and cardiometabolic diseases using integrated technology platforms.
TrueCardium™ Preclinical Organoid Model
A precision preclinical organoid model used for validating therapeutic targets and drug candidates in cardiovascular disease research.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown
obfuscation
Venture Round - Genome Biologics Logo
Venture Round - Genome Biologics
1
obfuscation
European Innovation CouncilVenture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

334
187.93%
 in past month

IT Spend

$267.9KThis year, Genome Biologics is projected to spend $267.9K on IT, according to Aberdeen.

Active Website Tech Count

4Genome Biologics is actively using 4 technologies for its website, according to BuiltWith. These include Viewport Meta, Euro, and  CommonCrawl Top 10m.

Total IP

8The intellectual property of Genome Biologics includes 8 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Genome Biologics's headquarters? Genome Biologics is located in Hessen, Sachsen-Anhalt, Germany.Who invested in Genome Biologics? Genome Biologics has 2 investors including European Innovation Council and  EISMEA.When was the last funding round for Genome Biologics? Genome Biologics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Genome Biologics's competitors? Alternatives and possible competitors to Genome Biologics may include Alnylam Pharmaceuticals, Novartis, and  Insitro.How much funding has Genome Biologics raised to date? Genome Biologics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|